معرفی
Mingxiu Hu is an Adjunct Professor of Biostatistics at the Yale School of Public Health and a recognized expert in statistical methodologies for drug development. He currently serves as Senior Vice President, Data Science and Systems at Nektar Therapeutics, following prior leadership roles at Takeda Pharmaceuticals and Pfizer.
- Ph.D. in Statistics, George Washington University
- M.S. in Statistics, Peking University
- M.A. in Biology, Brown University
Dr. Hu specializes in clinical trial designs, biomarker strategies, and longitudinal data analysis, with a focus on adaptive designs and missing data imputation. His work emphasizes statistical innovation in pharmaceutical research and global clinical trial harmonization.
His publications and software tools, including IVIVC Modeling SAS Macro and REE SAS Macro, have advanced methodologies for drug development and robust statistical estimation. He has authored over 20 scientific articles and two books.
- Fellow, American Statistical Association
- Featured in PharmaVoice for clinical trial innovations
- Leadership roles in ASA Board of Directors and Fellow Selection Committee
